Company news

DBV Technologies SA news in 2025

DBV Technologies SA's news releases, calls and decks from 2025, newest first.

View company

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years

December 17, 2025

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

December 16, 2025

ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America

December 1, 2025

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years

November 11, 2025

DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

November 4, 2025

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

November 3, 2025

DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors

October 30, 2025

DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting

October 30, 2025

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq

October 29, 2025

DBV Technologies Reports Third Quarter 2025 Financial Results

October 28, 2025

DBV Technologies Announces Resignation of Board Member

September 18, 2025

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

September 5, 2025

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

September 3, 2025

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

July 29, 2025

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

July 29, 2025

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer

July 22, 2025

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old

June 25, 2025

DBV Technologies to Participate in Upcoming EAACI Congress 2025

June 12, 2025

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

June 11, 2025

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

June 3, 2025

Combined General Meeting of June 11, 2025

May 15, 2025

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

May 5, 2025

DBV Technologies Reports First Quarter 2025 Financial Results

April 30, 2025

Calls in 2025

Decks in 2025